{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:04:56Z","timestamp":1789628696815,"version":"build-2803163510"},"reference-count":25,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tjh"],"DOI":"10.4274\/tjh.galenos.2026.33678","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:11:02Z","timestamp":1784200262000},"source":"Crossref","is-referenced-by-count":0,"title":["Establishment of a Multimodal Prognostic Prediction Model for Multiple Myeloma Patients Based on Radiomics and Clinical Features: A Retrospective Cohort Study"],"prefix":"10.4274","author":[{"given":"Shiqi","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1 Ma, X., & Zhang, X. (2025). Research progress of diabetic osteoporosis: a comprehensive review. Front Endocrinol (Lausanne), 16, 1595228. https:\/\/doi.org\/10.3389\/fendo.2025.1595228","DOI":"10.3389\/fendo.2025.1595228"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2 Netto, J. P., Pires, V. C., & Castro, M. G. M. (2025). Diabetic Bone Disease: A Comprehensive Narrative Review of Pathophysiology, Diagnosis, and Evidence-Based Management. Diabetology, 6(11), 140. https:\/\/doi.org\/10.3390\/diabetology6110140","DOI":"10.3390\/diabetology6110140"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3 Chen, R. (2026). Discussion on the Biological Mechanism of Kidney-Tonifying and Spleen-Strengthening Therapy in Intervening Osteoporosis Based on the Gut-Bone Axis Theory. Advances in Clinical Medicine.DOI: 10.12677\/acm.2026.1652109","DOI":"10.12677\/acm.2026.1652109"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.70063","article-title":"Morroniside Improves Diabetic Osteoporosis via the AGE\/RAGE\/Wnt\/\u03b2\u2010Catenin Signaling Pathway","author":"Yang","year":"2025","unstructured":"4 Yang, L., Wang, K., Zeng, Z., Zhao, H., & Bai, L. (2025). Morroniside Improves Diabetic Osteoporosis via the AGE\/RAGE\/Wnt\/\u03b2\u2010Catenin Signaling Pathway. The Kaohsiung Journal of Medical Sciences, 41.","journal-title":"The Kaohsiung Journal of Medical Sciences 41"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5 Luo M, Zhao Z and Yi J (2023) Osteogenesis of bone marrow mesenchymal stem cell in hyperglycemia. Front. Endocrinol. 14:1150068. doi: 10.3389\/fendo.2023.1150068","DOI":"10.3389\/fendo.2023.1150068"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6 Wongdee, K., Krishnamra, N., & Charoenphandhu, N. (2017). Derangement of calcium metabolism in diabetes mellitus: negative outcome from the synergy between impaired bone turnover and intestinal calcium absorption. The journal of physiological sciences : JPS, 67(1), 71-81. https:\/\/doi.org\/10.1007\/s12576-016-0487-7","DOI":"10.1007\/s12576-016-0487-7"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7 Forner, P., & Sheu, A. (2024). Bone Health in Patients With Type 2 Diabetes. Journal of the Endocrine Society, 8(7), bvae112. https:\/\/doi.org\/10.1210\/jendso\/bvae112","DOI":"10.1210\/jendso\/bvae112"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8 Murray, C. E., & Coleman, C. M. (2019). Impact of Diabetes Mellitus on Bone Health. International journal of molecular sciences, 20(19), 4873. https:\/\/doi.org\/10.3390\/ijms20194873","DOI":"10.3390\/ijms20194873"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9 Gazzotti, S., Aparisi G\u00f3mez, M. P., Schileo, E., Taddei, F., Sangiorgi, L., Fusaro, M., Miceli, M., Guglielmi, G., & Bazzocchi, A. (2023). High-resolution peripheral quantitative computed tomography: research or clinical practice?. The British journal of radiology, 96(1150), 20221016. https:\/\/doi.org\/10.1259\/bjr.20221016","DOI":"10.1259\/bjr.20221016"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10 Saito, M., & Marumo, K. (2013). Bone quality in diabetes. Frontiers in endocrinology, 4, 72. https:\/\/doi.org\/10.3389\/fendo.2013.00072","DOI":"10.3389\/fendo.2013.00072"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11 Cavati, G., Pirrotta, F., Merlotti, D., Ceccarelli, E., Calabrese, M., Gennari, L., & Mingiano, C. (2023). Role of Advanced Glycation End-Products and Oxidative Stress in Type-2-Diabetes-Induced Bone Fragility and Implications on Fracture Risk Stratification. Antioxidants (Basel, Switzerland), 12(4), 928. https:\/\/doi.org\/10.3390\/antiox12040928","DOI":"10.3390\/antiox12040928"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12 Asadipooya K and Greene LW (2026) Bone mineral density assessment by DXA in disease-associated osteoporosis: the limitations. Front. Endocrinol. 17:1768509. doi: 10.3389\/fendo.2026.1768509","DOI":"10.3389\/fendo.2026.1768509"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13 Li, Z. P., Luo, C., Yu, X. M., Ye, L. Y., Sun, D., Duan, C. Z., Xu, S. Y., Zeng, M. Q., Xu, H., Peng, Z. Y., Wang, P., Wang, Y. B., Ruan, W. J., Xue, M. E., Zhang, C. J., & He, D. J. (2025). Diabetic bone fragility through advanced glycation end product-collagen axis: Mechanisms and therapy of sodium glucose cotransporter 2 inhibitors. World journal of diabetes, 16(10), 111813. https:\/\/doi.org\/10.4239\/wjd.v16.i10.111813","DOI":"10.4239\/wjd.v16.i10.111813"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14 Yang J, Zhang Y, Liu X, Chen B and Lei L (2024) Effect of type 2 diabetes on biochemical markers of bone metabolism: a meta-analysis. Front. Physiol. 15:1330171. doi: 10.3389\/fphys.2024.1330171","DOI":"10.3389\/fphys.2024.1330171"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15 Sipeng Ding;Jing Wu;Daguo Cai;Youqi Yu;Song Peng. Research Progress of Traditional Chinese Medicine and Western Medicine on Diabetes Osteoporosis[J]. Traditional Chinese Medicine, 2023, 12(8): 2114-2120. https:\/\/doi.org\/10.12677\/TCM.2023.128315","DOI":"10.12677\/TCM.2023.128315"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16 Lei, S. S., Wang, Y. Y., Huang, X. W., Wang, X. P., Gao, M., & Li, B. (2025). Epimedium brevicornum Maxim alleviates diabetes osteoporosis by regulating AGE-RAGE signaling pathway. Molecular medicine (Cambridge, Mass.), 31(1), 101. https:\/\/doi.org\/10.1186\/s10020-025-01152-2","DOI":"10.1186\/s10020-025-01152-2"},{"key":"ref16","unstructured":"17 Lu HONG ,Suyao ZHANG ,Da CHEN ,Jianbo CHEN. Observation on the clinical efficacy of Bushen Zhuanggu Formula in treating diabetic osteoporosis with kidney-yang deficiency[J]. Journal of Changchun University of Chinese Medicine, 2026, 42(03): 347-352 DOI:10.13463\/j.cnki.cczyy.2026.03.019"},{"key":"ref17","unstructured":"18 LU JiaJin,QI BaoYu,JIN ZiKai,SUN ChuanRui,DONG YongLi & WEI Shu.(2024)..Research Progress on the Treatment of Primary Osteoporosis with Kidney Tonifying,Spleen Strengthening,and Blood Activating Prescriptions.Journal of Basic Chinese Medicine,30 (3),556-562. https:\/\/doi.org\/10.19945\/j.cnki.issn.1006-3250.2024.03.036."},{"key":"ref18","unstructured":"19 ZHANG Yanling\uff0c HUANG Yalan\uff0c XIAO Fan1\uff0c LYU Xialin1\uff0c LIU Xiu1\uff0c3\uff0c WU Yongjun4\uff0c YU Rong\uff0eEffect of Jingui Shenqiwan on Diabetic Osteoporosis in Mice via AGEs\/RANKL\/NF-\u03baB Pathway Based on Theory of \"Kidneys Governing Bones\"[J]\uff0eChinese Journal of Experimental Traditional Medical Formulae,2023,29(14):11-20\uff3bdoi\uff3d 10.13422\/j.cnki.syfjx.20230906"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20 Hu, S. J., Chen, G. C., Wang, F. Y., Fang, Y. Q., Wang, S. Q., Song, Z. L., Zhao, Z. H., Zhang, Q. L., Meng, X. Y., Zhang, Q. Y., & Qin, L. P. (2025). Network pharmacology analysis uncovers the mechanism of Shudihuang-Shanzhuyu herb pair in prevention and treatment of diabetic osteoporosis via PI3K\/AKT pathway. Journal of ethnopharmacology, 345, 119581. https:\/\/doi.org\/10.1016\/j.jep.2025.119581","DOI":"10.1016\/j.jep.2025.119581"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21 Yuchi He, Ya Liu. Exploration of the Molecular Mechanism of Liuwei Dihuang in Treating Diabetes-Related Osteoporosis Based on Network Pharmacology and Molecular Docking[J]. Traditional Chinese Medicine, 2025, 14(7): 2882-2888. https:\/\/doi.org\/10.12677\/tcm.2025.147423","DOI":"10.12677\/tcm.2025.147423"},{"key":"ref21","unstructured":"22 WEN Xiaochen, YANG Fang, LIU Ruoshi, et al. Exploration on the mechanism of tonifying kidney and strengthening spleen method in treating diabetic osteoporosis based on the IGF-1\/IRS-1\/PI3K signaling pathway[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2025, 40(12): 5502-5508 https:\/\/doi.org\/10.88888\/j.1673-1727.2025.12.5502-5508"},{"key":"ref22","unstructured":"23 Airu LIU ,Juanjuan GAO ,Defeng LIU ,Wenhui JIANG ,Wenxia YU ,Peng ZHANG , Xiuhai SU ,Congxiang WANG. Improvement effect of Jianpi Yiqi Huoxue decoction on bone metabolism in patients with type 2 diabetes mellitus combined with osteoporosis[J]. Jilin Journal of Chinese Medicine, 2026, 46(3): 331-335 DOI:10.13463\/j.cnki.jlzyy.2026.03.014"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24 Wang, K., Dang, X., Wang, Y., Yang, Q., Zhang, T., Yang, P., Yuan, L., Xu, R., Dang, Y., & Nan, Y. (2024). Qianggu concentrate: unlocking bone protection power via antioxidative SIRT1\/NRF2\/HO-1 pathways in type 2 diabetic osteoporosis. Frontiers in pharmacology, 15, 1426767. https:\/\/doi.org\/10.3389\/fphar.2024.1426767","DOI":"10.3389\/fphar.2024.1426767"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25 Zhou, T., Yu, Y., Yang, S., Xiao, F., Yu, R., & Zhang, G. (2026). Molecular mechanisms and preclinical evidence of natural products in diabetic osteoporosis: a review. Frontiers in endocrinology, 17, 1793925. https:\/\/doi.org\/10.3389\/fendo.2026.1793925","DOI":"10.3389\/fendo.2026.1793925"}],"container-title":["Turkish Journal of Hematology"],"original-title":[],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:33:35Z","timestamp":1789626815000},"score":1,"resource":{"primary":{"URL":"https:\/\/pdf.journalagent.com\/tjh\/pdfs\/TJH_43_3_213_223.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":25,"URL":"https:\/\/doi.org\/10.4274\/tjh.galenos.2026.33678","relation":{},"ISSN":["1300-7777","1308-5263"],"issn-type":[{"value":"1300-7777","type":"print"},{"value":"1308-5263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]}}}